1. Home
  2. APLT vs HBB Comparison

APLT vs HBB Comparison

Compare APLT & HBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • HBB
  • Stock Information
  • Founded
  • APLT 2016
  • HBB 1904
  • Country
  • APLT United States
  • HBB United States
  • Employees
  • APLT N/A
  • HBB N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • HBB Home Furnishings
  • Sector
  • APLT Health Care
  • HBB Consumer Discretionary
  • Exchange
  • APLT Nasdaq
  • HBB Nasdaq
  • Market Cap
  • APLT 178.6M
  • HBB 196.2M
  • IPO Year
  • APLT 2019
  • HBB 2017
  • Fundamental
  • Price
  • APLT $1.30
  • HBB $14.55
  • Analyst Decision
  • APLT Buy
  • HBB
  • Analyst Count
  • APLT 5
  • HBB 0
  • Target Price
  • APLT $4.13
  • HBB N/A
  • AVG Volume (30 Days)
  • APLT 5.5M
  • HBB 25.2K
  • Earning Date
  • APLT 11-10-2025
  • HBB 10-29-2025
  • Dividend Yield
  • APLT N/A
  • HBB 3.30%
  • EPS Growth
  • APLT N/A
  • HBB N/A
  • EPS
  • APLT N/A
  • HBB 2.35
  • Revenue
  • APLT $121,000.00
  • HBB $631,318,000.00
  • Revenue This Year
  • APLT N/A
  • HBB N/A
  • Revenue Next Year
  • APLT $5,935.35
  • HBB N/A
  • P/E Ratio
  • APLT N/A
  • HBB $6.20
  • Revenue Growth
  • APLT N/A
  • HBB N/A
  • 52 Week Low
  • APLT $0.30
  • HBB $12.72
  • 52 Week High
  • APLT $10.62
  • HBB $31.12
  • Technical
  • Relative Strength Index (RSI)
  • APLT 62.38
  • HBB 47.13
  • Support Level
  • APLT $1.16
  • HBB $14.48
  • Resistance Level
  • APLT $1.50
  • HBB $15.20
  • Average True Range (ATR)
  • APLT 0.15
  • HBB 0.57
  • MACD
  • APLT -0.01
  • HBB -0.02
  • Stochastic Oscillator
  • APLT 66.64
  • HBB 35.05

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About HBB Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.

Share on Social Networks: